SIC
REGN icon

Samalin Investment Counsel’s Regeneron Pharmaceuticals REGN Stock Holding History

Samalin Investment Counsel’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-511
Closed -$395K – 351
2026
Q1 		$395K Sell
511
-10
-2% -$7.66K 0.14% 202
2025
Q4 		$402K Sell
521
-15
-3% -$10.2K 0.14% 200
2025
Q3 		$301K Buy
536
+13
+2% +$7.35K 0.1% 243
2025
Q2 		$275K Sell
523
-350
-40% -$195K 0.11% 262
2025
Q1 		$554K Buy
873
+117
+15% +$80.5K 0.22% 138
2024
Q4 		$539K Sell
756
-35
-4% -$29.4K 0.23% 132
2024
Q3 		$832K Buy
791
+103
+15% +$115K 0.36% 77
2024
Q2 		$723K Buy
688
+5
+0.7% +$4.85K 0.34% 83
2024
Q1 		$657K Sell
683
-22
-3% -$20.9K 0.31% 95
2023
Q4 		$619K Sell
705
-5
-0.7% -$4.12K 0.31% 100
2023
Q3 		$584K Sell
710
-8
-1% -$6.29K 0.34% 90
2023
Q2 		$516K Sell
718
-40
-5% -$30.8K 0.28% 107
2023
Q1 		$623K Sell
758
-4
-0.5% -$3.02K 0.38% 74
2022
Q4 		$550K Sell
762
-53
-7% -$39.1K 0.35% 87
2022
Q3 		$561K Buy
815
+43
+6% +$27.1K 0.41% 67
2022
Q2 		$456K Sell
772
-187
-19% -$122K 0.32% 96
2022
Q1 		$670K Hold
959
– – 0.41% 70
2021
Q4 		$606K Hold
959
– – 0.36% 77
2021
Q3 		$580K Buy
959
+44
+5% +$27.3K 0.38% 77
2021
Q2 		$511K Buy
+915
New +$464K 0.33% 99
2020
Q1 		– Sell
-100
Closed -$37K – 438
2019
Q4 		$37K Buy
+100
New +$33.6K 0.03% 317

Other funds holding REGN

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
MCI
McDonald Capital Investors Orinda, California $1.37B AUM 1.88% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Retirement Systems of Alabama
Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

Samalin Investment Counsel's REGN Position: Q2 2026 in Review

Samalin Investment Counsel sold out of Regeneron Pharmaceuticals (REGN) in Q2 2026, closing a stake of 511 shares — an estimated $395K sold.

Samalin Investment Counsel first reported a position in REGN in Q4 2019 and held it in 21 quarters. The position peaked at $832K in Q3 2024. 518 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Samalin Investment Counsel reported no remaining Regeneron Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Samalin Investment Counsel sold 511 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $395K.
  • Samalin Investment Counsel first reported a position in Regeneron Pharmaceuticals in Q4 2019 and held it in 21 quarters.
  • Samalin Investment Counsel's Regeneron Pharmaceuticals position peaked at $832K in Q3 2024.
  • 518 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Samalin Investment Counsel's 13F filing for Q2 2026, filed 27 Jul 2026.